ZLAB - NovoCure gains on participation at J.P. Morgan Healthcare Conf.
2023-12-27 14:59:02 ET
More on NovoCure
- NovoCure: Significant Upside Even Without A Breakthrough
- NovoCure Limited 2023 Q3 - Results - Earnings Call Presentation
- NovoCure Limited (NVCR) Q3 2023 Earnings Call Transcript
- Novocure to eliminate 13% of workforce in restructuring effort
- NovoCure GAAP EPS of -$0.46 beats by $0.07, revenue of $127.32M misses by $1.44M
For further details see:
NovoCure gains on participation at J.P. Morgan Healthcare Conf.